Main Menu

UW Launches Clinical Trial on CBD Treatment for Autism

UW Launches Clinical Trial on CBD Treatment for Autism

Lester Black | Apr 2, 2019

There is no current therapy for Fragile X syndrome, a form of autism caused by a genetic mutation that leads to a range of developmental problems. But that could soon change. Researchers across the country, including one scientist at University of Washington, are launching a clinical trial looking at how a topical CBD gel can reduce the symptoms of this genetic disorder.

Dr. Raphael “Raphe” Bernier, the University of Washington professor leading the Seattle clinical trials, said the trial hopes to specifically reduce the social aspects of the Fragile X syndrome.

UW Launches Clinical Trial on CBD Treatment for Autism






Leave a Reply

Your email address will not be published. Required fields are marked *